CSL:ASX 1H21 NPAT of US$1.8bn. FY21 guidance retained at US$2.2bn, which implies a weaker 2H21.
We expect to see earnings upgraded prior to the completion of the 2H.
You're not a member! Trial today
CSL trades on a forward yield of 1%.
Posted on | by Leon Hinde
